Stock Titan Trading tools for traders and investors.

-

12:26:15 PM

Last TRHC Stock Market News

TRHC - Tabula Rasa HealthCare Inc

02/23/21 9:42 PM

Nasdaq : TRHC

Tabula Rasa HealthCare Reports Fourth Quarter and Full Year 2020 Results

Tabula Rasa HealthCare, Inc. ("TRHC") (Nasdaq: TRHC), a healthcare technology company advancing the safe use of medications, today reported financial results for the fourth quarter and full year ended December 31, 2020. "We finished a challenging 2020

RHEA-AI

neutral

02/23/21 8:00 AM

Nasdaq : TRHC

Tabula Rasa HealthCare and ASHP Partner to Facilitate Use of MedWise(TM) Software, Improve the Safe Use of Medications in Health Systems

Tabula Rasa HealthCare ("TRHC") (NASDAQ:TRHC), a healthcare technology company advancing safe use of medications, and ASHP (American Society of Health-System Pharmacists) today announced a collaboration to establish best practices

RHEA-AI

very positive

02/22/21 8:00 AM

Nasdaq : TRHC

Tabula Rasa HealthCare to Provide Innovative Medication Risk Mitigation Technology to National Primary Care Network MDVIP

Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ: TRHC), a healthcare technology company advancing safe use of medication, today announced it has entered into an agreement expanding its existing relationship with the national primary care network, MDVIP

RHEA-AI

neutral

02/16/21 8:15 AM

Nasdaq : TRHC

PrimeRx(TM) and Tabula Rasa HealthCare Now Offer Integration Technology for Automated COVID-19 Vaccine Reporting

Micro Merchant Systems announces that its PrimeRx(TM) pharmacy technology software offers direct integration with the automated immunization reporting solution offered by Tabula Rasa HealthCare's (TRHC) Script Management Partners (SMP). With this

RHEA-AI

neutral

02/11/21 8:00 AM

Nasdaq : TRHC

Tabula Rasa HealthCare Fourth Quarter and Full Year 2020 Earnings Conference Call Announcement

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its fourth quarter and full year 2020 operating results on Wednesday, February 24, 2021 at 8:30 a.m. EDT . The conference call will be hosted by TRHC CEO,

RHEA-AI

neutral

02/03/21 8:00 AM

Nasdaq : TRHC

Tabula Rasa HealthCare Deploys MedWise Risk Score(TM) Technology to PrescribeWellness Community Pharmacy Network

Tabula Rasa HealthCare, Inc (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the safe use of medications, today announced the integration of its MedWise Risk Score(TM) into PrescribeWellness (PW) software, TRHC's leading patient

RHEA-AI

neutral

01/28/21 8:00 AM

Nasdaq : TRHC

Tabula Rasa HealthCare Partners with RxResults to Provide Pharmacy Risk Management for Health Plans

Tabula Rasa HealthCare, Inc. "TRHC" (NASDAQ: TRHC), a healthcare technology company advancing safe use of medications, today announced a partnership with RxResults, an evidence-based pharmacy risk management firm, to develop a new competitive model

RHEA-AI

neutral

01/19/21 8:00 AM

Nasdaq : TRHC

American Society of Health-System Pharmacists and Tabula Rasa HealthCare Partner to Offer Vancomycin Bayesian Dosing Solution for Members

American Society of Health-System Pharmacists (ASHP) and Tabula Rasa HealthCare ("TRHC") (NASDAQ:TRHC) today announced the organizations have partnered to provide TRHC's market-leading Bayesian Dosing platform, DoseMeRx (TM), to

RHEA-AI

positive

01/11/21 8:00 AM

Nasdaq : TRHC

Tabula Rasa HealthCare and Innovative Integrated Health Community Plans, Inc. Collaborate to Build Medicare Advantage Program

Tabula Rasa HealthCare, Inc. "TRHC" (NASDAQ:TRHC), a healthcare technology company advancing safer use of medications, today announced it has entered into an agreement with Innovative Integrated Health Community Plans, Inc. (IIHCP) to provide an array

RHEA-AI

very positive

12/29/20 8:00 AM

Nasdaq : TRHC

Tabula Rasa HealthCare to Participate in Upcoming J.P. Morgan Investor Conference

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), today announced CEO, Chairman and Founder, Calvin H. Knowlton, Ph.D.; Co-Founder, President, Chief Marketing and Business Development Officer, Orsula V. Knowlton, PharmD; Chief Sales Officer, Kevin

RHEA-AI

neutral